BioMotiv, the for-profit accelerator of The Harrington Project, is the developer and lead funder for Z53 Therapeutics. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.
Learn more about BioMotiv here.
Become a Partner
We are open to partnering with other organizations. Please reach out to us via the form below if you or your company are interested in partnering with Z53 Therapeutics.